High Dose IMVAMUNE® in Vaccinia-Naive Individuals

NCT00879762 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

NIH

Sponsor class

Conditions

Smallpox

Interventions

BIOLOGICAL: MVA Smallpox Vaccine
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)